These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38949165)

  • 21. Retraction: miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
    J Cell Mol Med; 2024 Feb; 28(4):e18188. PubMed ID: 38396328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retraction: Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Li-Li Wang, Wei-Wei Huang, Jing Huang, Rong-Fang Huang, Na-Ni Li, Yi Hong, Mu-Lan Chen, Fan Wu, Jian Liu, Kaohsiung J Med Sci. 2020; 36(8): 581-591 (https://doi.org/10.1002/kjm2.12212).
    Kaohsiung J Med Sci; 2023 Dec; ():. PubMed ID: 38088487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction.
    Cancer Med; 2023 Dec; 12(24):22437. PubMed ID: 38100296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781-790.
    FEBS Open Bio; 2023 Aug; 13(8):1539. PubMed ID: 37219057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
    Mol Oncol; 2023 Jul; 17(7):1453. PubMed ID: 37231579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    J Cell Mol Med; 2024 Apr; 28(8):e18314. PubMed ID: 38655709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retraction.
    J Thromb Haemost; 2021 Aug; 19(8):2096. PubMed ID: 33314547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820.
    FEBS Open Bio; 2023 Aug; 13(8):1537. PubMed ID: 37219054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retraction.
    Cancer Med; 2023 May; 12(10):12034. PubMed ID: 37097252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RETRACTION: Long Non-Coding RNA CRNDE Sponges miR-384 to Promote Proliferation and Metastasis of Pancreatic Cancer Cells through Upregulating IRS1.
    Cell Prolif; 2024 Jun; ():e13690. PubMed ID: 38853619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retraction: Wang Y, Yue D. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
    Cancer Med; 2024 Apr; 13(7):e7138. PubMed ID: 38546000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RETRACTION: Six2 Promotes Non-Small Cell Lung Cancer Cell Stemness Via Transcriptionally and Epigenetically Regulating E-Cadherin.
    Cell Prolif; 2024 Jul; 57(7):e13682. PubMed ID: 38804816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.
    J Cell Mol Med; 2024 Mar; 28(6):e18078. PubMed ID: 38073225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retraction: IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling.
    FEBS Open Bio; 2024 Mar; 14(3):527. PubMed ID: 38149381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retraction.
    Cancer Sci; 2023 Jul; 114(7):3056. PubMed ID: 37166008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawn: Circ-SOX4 promotes non-small cell lung cancer progression by activating the Wnt/β-catenin pathway.
    Mol Oncol; 2020 Dec; 14(12):3253. PubMed ID: 32112500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retraction statement: MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway.
    FEBS Lett; 2021 May; 595(9):1388. PubMed ID: 34048597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retraction Statement: MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma.
    FEBS Lett; 2022 Nov; 596(21):2851. PubMed ID: 36308001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retraction: Disruption of microRNA-214 during general anaesthesia prevents brain injury and maintains mitochondrial fusion by promoting Mfn2 interaction with Pkm2.
    J Cell Mol Med; 2024 Jan; 28(2):e18095. PubMed ID: 38153171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction statement: Dai, Y., Xie, F. and Chen, Y. (2020), Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10: 1348-1361.
    FEBS Open Bio; 2023 Aug; 13(8):1538. PubMed ID: 37219053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.